OncoVista Innovative Therapies (OncoVista Innovative Therapies) Total Stockholders Equity : $-6.59 Mil (As of Sep. 2015)

View and export this data going back to 2005. Start your Free Trial

What is OncoVista Innovative Therapies Total Stockholders Equity?

OncoVista Innovative Therapies's Total Stockholders Equity for the quarter that ended in Sep. 2015 was $-6.59 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. OncoVista Innovative Therapies's Book Value per Share for the quarter that ended in Sep. 2015 was $-0.28. The ratio of a company's debt over equity can be used to measure how leveraged this company is. OncoVista Innovative Therapies's Debt-to-Equity for the quarter that ended in Sep. 2015 was -0.07.

OncoVista Innovative Therapies Total Stockholders Equity Historical Data

The historical data trend for OncoVista Innovative Therapies's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoVista Innovative Therapies Total Stockholders Equity Chart

OncoVista Innovative Therapies Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Total Stockholders Equity

Get a 7-Day Free Trial

1.66

-0.12

-1.68

-3.12

-5.66

OncoVista Innovative Therapies Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Total Stockholders Equity	Get a 7-Day Free Trial															-4.09	-5.66	-5.94	-7.04	-6.59

OncoVista Innovative Therapies (OTCPK:OVIT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

OncoVista Innovative Therapies's Book Value per Share for the quarter that ended in Sep. 2015 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-6.59	-	0)	/	23.5585
	=	-0.28

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

OncoVista Innovative Therapies's Debt-to-Equity for the quarter that ended in Sep. 2015 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.479	+	0)	/	-6.59
	=	-0.07

OncoVista Innovative Therapies Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of OncoVista Innovative Therapies's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoVista Innovative Therapies Inc (OTCPK:OVIT) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245

Website

http://www.oncovista.com

OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.

Executives

Alexander Ruckdaeschel	director	123 EAST 83RD STREET, APT 3-B, NEW YORK NY 10028
Paul A Mieyal	director	C/O WEXFORD CAPITAL LP, 411 WEST PUTNAM AVE, SUITE 125, GREENWICH CT 06830
Charles E Davidson	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH FL 33401
Wexford Capital Lp	10 percent owner	777 WEST PUTNAM AVENUE, 1ST FLOOR, GREENWICH CT 06830
Joseph Jacobs	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH FL 33401
Wexford Spectrum Trading Ltd	10 percent owner	411 WEST PUTNAM AVENUE, SUITE 125, GREENWICH CT 06830

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Headlines

No Headlines